L.A. hospital cuts hospital stays, adds video-call exams
More than 500 patients have participated in L.A. General's Safer at Home program, cared for remotely by several dozen nurses and five physicians.
Stay updated with breaking news from Josh Banerjee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than 500 patients have participated in L.A. General's Safer at Home program, cared for remotely by several dozen nurses and five physicians.
Government Executive Get the latest on need-to-know topics for federal employees delivered to your inbox. email The reputation of all COVID-19 vaccines hinges on improving perceptions of the Johnson and Johnson shot. Katherine J. Wu , Had Johnson & Johnson’s COVID-19 vaccine been the first to get the FDA’s green light, it might have been hailed from the get-go for what it actually is: a scientific and technological marvel. It requires just one injection to confer full immunity—a boon for needlephobes and tough-to-reach populations who can’t easily access a ...